Cargando…

Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?

Detalles Bibliográficos
Autores principales:	Muthukumar, Thangamani, Crew, R. John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039899/ https://www.ncbi.nlm.nih.gov/pubmed/35497807 http://dx.doi.org/10.1016/j.ekir.2022.02.026

Ejemplares similares

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Post-Transplant Hypotension in Kidney Recipients—Vasopressin to the Rescue?
por: Bajpai, Divya, et al.
Publicado: (2022)

Can COVID-19 innovations and systems help low- and middle-income countries to re-imagine healthcare delivery?
por: Saha, Senjuti, et al.
Publicado: (2021)

Discovering chronic pain treatments: better animal models might help us get there
por: Taylor, Norman E., et al.
Publicado: (2023)

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
por: Nickerson, Peter W., et al.
Publicado: (2022)

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
por: Jordan, Stanley C., et al.
Publicado: (2022)

Imagine all you want, but…
por: Ley, Taran
Publicado: (2022)

Imagining Interventions for Collective Sex Environments
por: Flowers, Paul, et al.
Publicado: (2018)

How can behavioural science help us design better trials?
por: Gillies, Katie, et al.
Publicado: (2021)

Non-invasive screening for sub-clinical antibody-mediated rejection as a new tool for indication of kidney allograft biopsy
por: Kozakowski, Nicolas
Publicado: (2019)

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
por: Meletiadis, Joseph, et al.
Publicado: (2020)

Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
por: Chedid, Marcio F., et al.
Publicado: (2019)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

Imaging of insulin factory: Is it just imagination or approaching reality?
por: Yagihashi, Soroku
Publicado: (2012)

Imagining Simpler Worlds to Understand the Complexity of Our Own
por: Gerber, Edwin P., et al.
Publicado: (2019)

Transdisciplinary Imagination: Addressing Equity and Mistreatment in Perinatal Care
por: Vedam, Saraswathi, et al.
Publicado: (2022)

A world without tuberculosis: moving from imagination to reality
por: Jacobs, William R.
Publicado: (2022)

The Role of Interleukin-6 in Bone
por: Lorenzo, Joseph A
Publicado: (2020)

Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts
por: Dooley, Bryan J., et al.
Publicado: (2020)

Bridging the ‘Two Cultures’ of Research and Service: Can Complexity Theory Help?: Comment on "Experience of Health Leadership in Partnering With University-Based Researchers in Canada – A Call to ‘Re-imagine’ Research"
por: Greenhalgh, Trisha
Publicado: (2019)

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
por: Widjaja, Anissa A., et al.
Publicado: (2020)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

Re-imagining Research: A Bold Call, but Bold Enough? Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Holmes, Bev J.
Publicado: (2019)

Promising Points for Intervention in Re-Imagining Partnered Research in Health Services Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada – A Call to ‘Re-imagine’ Research"
por: Canas, Eugenia, et al.
Publicado: (2020)

Can We Re-Imagine Research So It Is Timely, Relevant and Responsive? Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Vindrola-Padros, Cecilia
Publicado: (2020)

Alpha E: No More Rejection?
por: Kilshaw, Peter J., et al.
Publicado: (2002)

Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection?
por: Mubarak, M.
Publicado: (2016)

Re-imagining malaria – a platform for reflections to widen horizons in malaria control
por: Hausmann-Muela, Susanna, et al.
Publicado: (2015)

More and better investment now! How unlocking sustainable and digital investment flows can help achieve the SDGs
por: Stephenson, Matthew, et al.
Publicado: (2021)

Brain delivery of a virus to block seizures helps mice get a silent NACHT
por: Henshall, David C.
Publicado: (2019)

The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022)

Head in the clouds: Re-imagining the experimental laboratory record for the web-based networked world
por: Neylon, Cameron
Publicado: (2009)

Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019
por: Betts, Brian C., et al.
Publicado: (2020)

The Importance of CD11b(+) Dendritic Cells in CD4(+) T Cell Activation In Vivo: With Help from Interleukin 1
por: Iwasaki, Akiko
Publicado: (2003)

Re-imagining the control of malaria in tropical Africa during the early years of the World Health Organization
por: Litsios, Socrates
Publicado: (2015)

Is imagery better than reality? Performance in imagined dart throwing
por: Dahm, Stephan F., et al.
Publicado: (2019)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Chronic active antibody mediated rejection associated with human leukocyte antigen-C*07 antibodies
por: Dorwal, P., et al.
Publicado: (2016)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a408399c6s8fkdu22bg81lse7v